News aboutOkuvision & OkuStim®
Stay up to date: In Okuvision’s newsfeed you will find the latest posts for healthcare professionals, those affected, and anyone interested in TES therapy with OkuStim® for retinitis pigmentosa. Whether research, care, or everyday life – here we bring together medical content and insights into living with retinitis pigmentosa.
Sort blog posts by category
Education & Career: Achieving Disadvantage Compensation
Fair conditions without special privileges: How to apply for adjustments and implement them practically.
Interview: Founding & Vision
Alfred Stett on the journey from neurostimulation to evidence-based care—and what drives Okuvision.
Traveling with RP: Safe on the Road
From Booking to Boarding – reach your destination relaxed with planning, assistance, and orientation aids.
RP & Mental Health
Why RP is a burden – and what is proven to help: education, support, rehab, and preservation of function. With concrete strategies for everyday life.
EUTB®: Free Participation Counseling
Independent, individual, and accessible: EUTB® supports you – including with cost coverage applications for OkuStim® therapy.
Retroactive reimbursement of OkuStim® for RP
The LSG Lower Saxony-Bremen considers impending blindness in Retinitis pigmentosa (RP) to be an emergency-like situation and obliges a health insurance company to retroactively reimburse the OkuStim®…
RP: Myth Check – What’s Really True
Concise, clear, evidence-based: We dispel false expectations and show what is possible today.
Medical consultation: 10 questions that matter
Go in well-prepared, come out clearly informed: This checklist helps you understand findings and together take informed decisions.
Guideline 045/23: Electrostimulation for Retinitis pigmentosa (RP)
DOG, RG, and BVA name electrostimulation as a therapy option for Retinitis pigmentosa and refer to the G-BA trial study.
Note: For medical questions regarding your own treatment, please consult your specialist.